Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
**Sanye Tongzhiqing Tablets** is an oral traditional Chinese medicine product under clinical development for metabolic disorders. It has been studied in Phase 2 trials for type 2 diabetes mellitus and impaired glucose tolerance, with additional clinical investigation in hyperlipidemia and hypertriglyceridemia. The precise active-herb composition and molecular mechanism have not been publicly established in the sources reviewed; it is therefore best characterized as a proprietary herbal medicine intended to improve dysregulated glucose and lipid metabolism rather than as a defined single-target agent.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Sanye Tongzhiqing Tablets.